165 related articles for article (PubMed ID: 16396645)
1. Screening compliance and visual outcome in diabetes.
Zoega GM; Gunnarsdóttir T; Björnsdóttir S; Hreietharsson AB; Viggósson G; Stefánsson E
Acta Ophthalmol Scand; 2005 Dec; 83(6):687-90. PubMed ID: 16396645
[TBL] [Abstract][Full Text] [Related]
2. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
Kristinsson JK
Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
[TBL] [Abstract][Full Text] [Related]
3. Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease.
Olafsdottir E; Andersson DK; Stefánsson E
Acta Ophthalmol Scand; 2007 Feb; 85(1):40-5. PubMed ID: 17244208
[TBL] [Abstract][Full Text] [Related]
4. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
Henricsson M; Nilsson A; Janzon L; Groop L
Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic retinopathy and associated risk factors in type-1 and type-2 diabetics in the Upper Palatinate].
Zietz B; Kasparbauer A; Ottmann S; Spiegel D; Palitzsch KD
Dtsch Med Wochenschr; 2000 Jun; 125(25-26):783-8. PubMed ID: 10916493
[TBL] [Abstract][Full Text] [Related]
6. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
Scanlon PH; Foy C; Chen FK
Br J Ophthalmol; 2008 Jun; 92(6):775-8. PubMed ID: 18356262
[TBL] [Abstract][Full Text] [Related]
7. Does functional vision behave differently in low-vision patients with diabetic retinopathy?--A case-matched study.
Ahmadian L; Massof R
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4051-7. PubMed ID: 18552389
[TBL] [Abstract][Full Text] [Related]
8. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
[TBL] [Abstract][Full Text] [Related]
9. The effect of low vision rehabilitation in diabetic eye disease: a randomised controlled trial protocol.
Dunbar HM; Crossland MD; Bunce C; Egan C; Rubin GS
Ophthalmic Physiol Opt; 2012 Jul; 32(4):282-93. PubMed ID: 22620493
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study.
Broadbent DM; Scott JA; Vora JP; Harding SP
Eye (Lond); 1999 Apr; 13 ( Pt 2)():160-5. PubMed ID: 10450374
[TBL] [Abstract][Full Text] [Related]
11. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
Wilczyński M; Dzivgielewski K
Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
[TBL] [Abstract][Full Text] [Related]
12. A portable visual acuity device used in diabetic retinal screening.
Kehler LF; Kehler KB; Merin LM; Tsai JC
Am J Ophthalmol; 2007 Mar; 143(3):514-5. PubMed ID: 17317400
[TBL] [Abstract][Full Text] [Related]
13. Sight-threatening diabetic retinopathy at presentation to screening services in Fiji.
Damato EM; Murray N; Szetu J; Sikivou BT; Emma S; McGhee CN
Ophthalmic Epidemiol; 2014 Oct; 21(5):318-26. PubMed ID: 25157913
[TBL] [Abstract][Full Text] [Related]
14. Diabetes eye screening in the Wellington region of New Zealand: characteristics of the enrolled population (2002-2005).
Frederikson LG; Jacobs RJ
N Z Med J; 2008 Mar; 121(1270):21-34. PubMed ID: 18364752
[TBL] [Abstract][Full Text] [Related]
15. Vision-related quality of life in patients with diabetic macular oedema.
Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
[TBL] [Abstract][Full Text] [Related]
16. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
17. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
[TBL] [Abstract][Full Text] [Related]
18. [Programme preventing vision loss due to diabetes].
Bandurska-Stankiewicz E; Wiatr D
Klin Oczna; 2007; 109(7-9):359-62. PubMed ID: 18260299
[TBL] [Abstract][Full Text] [Related]
19. Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes.
Soto-Pedre E; Hernaez-Ortega MC; Piniés JA
Ophthalmic Epidemiol; 2007; 14(2):76-9. PubMed ID: 17464854
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of state of the organ of sight in patients with diabetes type II].
Wilczyński M; Dziegielewski K
Klin Oczna; 2005; 107(10-12):672-4. PubMed ID: 16619817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
